Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact, top 89% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it, 0 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
9 authors at 5 institutions in 2 countries.
Sonia MaatougLaboratoire Biomolécules, Venins et Applications Théranostiques (LR20IPT01), Institut Pasteur de Tunis, Université Tunis El Manar, 13 Place Pasteur BP74, Tunis 1002, Tunisia.ORCID 0000-0002-6689-4938
Amani CheikhLaboratoire Biomolécules, Venins et Applications Théranostiques (LR20IPT01), Institut Pasteur de Tunis, Université Tunis El Manar, 13 Place Pasteur BP74, Tunis 1002, Tunisia.ORCID 0000-0002-9000-5184
Oussema KhamessiLaboratoire des Biomolécules Thérapeutiques, Institut Pasteur de Tunis, Université de Tunis El Manar, 13 Place Pasteur BP74, Tunis 1002, Tunisia.
Hager TabkaLaboratoire Biomolécules, Venins et Applications Théranostiques (LR20IPT01), Institut Pasteur de Tunis, Université Tunis El Manar, 13 Place Pasteur BP74, Tunis 1002, Tunisia.ORCID 0000-0001-7938-3486
Zied LandoulsiLaboratoire Biomolécules, Venins et Applications Théranostiques (LR20IPT01), Institut Pasteur de Tunis, Université Tunis El Manar, 13 Place Pasteur BP74, Tunis 1002, Tunisia.
Jean-Marie GuigonisLaboratory Transporter in Imaging and Radiotherapy in Oncology (TIRO), Direction de la Recherche Fondamentale (DRF), Institut des Sciences du Vivant Fréderic Joliot, Commissariat à l'Energie Atomique et aux Énergies Alternatives (CEA), Université Côte d'Azur, F-06107 Nice, France.
Sylvie DiochotInstitut de Pharmacologie Moléculaire et Cellulaire, Centre National de la Recherche Scientifique, Université Côte d'Azur, 660 Route des Lucioles, Sophia-Antipolis, 06560 Valbonne, France.
Rym BenkhalifaLaboratoire Biomolécules, Venins et Applications Théranostiques (LR20IPT01), Institut Pasteur de Tunis, Université Tunis El Manar, 13 Place Pasteur BP74, Tunis 1002, Tunisia.ORCID 0000-0002-6944-481X
Institut Pasteur de Tunis · TNUniversité Côte d'Azur · FRCentre National de la Recherche Scientifique · FRTunis University · TNUniversity of Carthage · TN
Funding
Ministry of Higher Education and Scientific Research AFM #19928Ministry of Higher Education and Scientific Research LR11IPT08
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Cross Pharmacological, Biochemical and Computational Studies of a Human Kv3.1b Inhibitor from · full record | OpenQuestion